Digwill International Pvt Ltd
Back to catalog
Ryverna (Crizanlizumab) Injection
Novartis India

Ryverna (Crizanlizumab) Injection

Ryverna is an intravenous infusion (given into a vein) used to treat sickle cell disease in adults and children aged 16 and older. Verteporfin Injection (Brand name Ryverna) is available in Delhi, India. Product Name Ryverna Salt Composition Verteporfin Injection Product Form / Net Quantity Injection: 10mg/ml Marketed By Novartis India Ltd. Availability In Stock at Aark Locations Prescription Required Buy 100% authentic medicines from Aark Pharmaceuticals. Top CFA & pharma distributor supplying hospitals, clinics & patients across India. * Get the best price & exclusive discounts on Ryverna Injection today! Call/WhatsApp Aark Pharmaceuticals at 9999156233 (Ms.Himanshi) for instant availability. Your Health Advantage: Certified Distributor, Trusted CFA Partner, Wholesale & Retail, Hospital

Therapy areaNovartis India
AvailabilityAvailable on order · Bulk enquiries welcome
DistributionPan-India · Cold-chain compliant
Request quotation

About Ryverna (Crizanlizumab) Injection

Description Is Crizanlizumab Injection available in India? Yes, It is available in India. Crizanlizumab Injection is the salt name for the drug sold under the brand name Ryverna. Crizanlizumab is indicated for the prevention of recurrent vaso occlusive crises in sickle cell disease patients aged 16 years and older. It can be given as an add on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate. Who is the CFA, distributor, and retailer for Visudyne (Crizanlizumab) Injection in India? Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Visudyne (Crizanlizumab) Injection in India. It is marketed by Novartis India Ltd . Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Novartis products, including advanced cancer treatments. The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup. How much do Ryverna Injection cost in Delhi, India? Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals Seller Name: Aark Pharmaceuticals Private Limited. Contact Person: Ms. Himanshi Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016. Mobile / WhatsApp : 9999156233 Email: sales@aarkpharma.co.in , sales@aarkpharma.com Our Branch Offices in India – New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur. Do you offer any discounts? Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price. Prior to consuming any medications, including Crizanlizumab Injection, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects. NEWS/UPDATE FDA broadens ceritinib indication to previously untreated ALK-positive metastatic NSCLC FDA Expands Approval of Ceritinib for ALK-Positive Non-Small Cell Lung Cancer Written By Mr. Sandeep Tomar (D. pharma) Last updated 12 June 2026 10:00 AM (IST)

Related products